Why Attend
The world shut down in 2020 as the pandemic had a global impact on trade and development, but the onco cell therapy industry remained resilient in the face of all of this. In spite of 69% of industry claiming that their biggest challenges in 2020 was meeting their projected timelines for their pipes, the race for bringing the first BCMA targeting CAR-T to the market is reaching a climax and next-generation cell therapies are at the front of mind for those in both industry and research.
Significant break throughs in GvHD for allogeneic treatments and in the use of alternative cell therapies mean that onco cell therapies are embedding themselves as the 5th pillar of oncology. New combination studies and manufacturing capabilities are showing even more promise for this sector, but with current treatments still having high costs of use and as there are limited patient pools, there are still challenges in both clinical and commercial use of these therapies.
The Onco Cell Therapy Summit (OCTS), November 17 - 18, Boston USA, brings the industry together to share novel research, manufacturing techniques, and regulatory best practice. Each session of OCTS 2021 is dedicated to the process of translating R&D into commercially viable oncological therapies.
We’ve worked with industry partners to ensure that OCTS 2021 is dedicated to the effective translation and commercialization of research into safe and efficacious therapies and address these challenges.
Meet our 2021 Industry- Leading Speakers
Dr. Kristen Hege
Frank Fan
Paul Rennert
Tony Ho
Pascal Touchon
Dr. Matthew Spear
Paul Lammers
James Trager
Peggy Sotiropoulou
Robert Hofmeister
Chris Heery
Gary Lee
Travis Young
Dan Shelly
Alice Brown
Hanspeter Gerber
Alan Trounson
Roman Yelensky
John Rossi
Adrian Bot
Dolores Schendel
Kristina Carroll
Kristina is a Process Engineer and founding member of the Cell Therapy Development team at Precision BioSciences, focused on the development of best-in-class manufacturing methods for allogeneic CAR T therapies. As an integral part of the CMC team, Kristina led in the development of the large-scale manufacturing process, cold chain logistics for the cryopreserved drug product, and clinical administration protocols. Prior to joining Precision BioSciences, Kristina worked as a Systems Engineer at Terumo BCT, focusing on upstream and downstream cell processing systems. She has earned her Master’s degree in Biomedical Engineering from Rutgers University and Bachelor’s degree in Chemical and Biological Engineering at the University of Colorado at Boulder. When not at Precision, Kristina can be found running nearby trails with her husband and dogs, camping, or creating a disaster in the kitchen.
Blake Aftab
Steve Kanner
Donna Rill
Krishnan Viswanadhan
Dr. Avery Posey
Frank Thielman
Steven Feldman
Dr. Steven A. Feldman was a Staff Scientist and Director of the Vector Production Facility at Surgery Branch, NCI for the past twelve years. Dr. Feldman’s group was responsible for the development, characterization, and manufacturing of the viral vectors used in gene therapy clinical trials at the Surgery Branch. Recently, Dr. Feldman joined the Stanford Center for Cancer Cell Therapy as Director of Manufacturing and Process Science where he will take a lead role in the development and manufacture of viral vectors and novel cell therapies for the treatment of cancer.
Emilie Gauthy
Nick Huntington
Hong Ma
Sponsors
Platinum Partner
Miltenyi Biotec
Website: http://www.miltenyibiotec.com
At Miltenyi Biotec, we are committed to enabling the delivery of new cell and gene therapy (CGT) treatment options to patients with unmet medical needs. We develop tailored cell processing protocols for our GMP-compliant cell processing platform, the CliniMACS Prodigy®, to enable fully closed and automated manufacturing of complex CGT products. In addition, we offer contract development and GMP manufacturing of CGT products as well as design, development, and production of tailored GMP lentiviral vectors
Gold Partner
nanoString
Website: https://www.nanostring.com/
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System, which has been employed in basic and translational research and cited in 1,000+ peer review publications, has also now been applied to diagnostic use with the nCounter Dx Analysis System. The company is committed to offering tools that enable scientists and clinicians to translate today’s leading genomic research into clinically actionable tests that improve patient care. Gene expression panels for immune- oncology, autoimmunity, CAR-T and other applications are ready off the shelf tools offered to the Nanostring customers.
American Red Cross
Website: https://www.redcross.org/
The Cell & Gene Therapy Solutions division of the American Red Cross is a nationwide leader in the provision of allogeneic and autologous collections for cell and gene therapy. Our products support a broad range of uses, from bench research to use in clinical trials and the manufacture of commercial therapies.
We currently perform autologous Mononuclear Cell collections at 62 Red Cross sites across the country and at multiple hospital locations. Our allogeneic Mononuclear Cell products are collected from healthy donors at five Red Cross sites across the country, and can be shipped fresh or frozen.
Our five full-service cellular therapy labs perform processing, freezing and storage of apheresis material. This, along with our ability to offer robust customization, allows us to both collect and process apheresis products according to our customers’ specifications and unique needs.
Event Partner
Lonza
Website: http://www.capsugel.com
Following the closing of the Capsugel acquisition, Lonza further strengthened its position as one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Lonza Consumer Health & Nutrition combines expertise in high-quality, science-backed ingredients with formulation know-how and industry-leading capsule and encapsulation technologies to create innovative solutions for consumer health and nutrition companies. Our deep clinical knowledge supports specialty ingredients with proven performance, enabling customers to address consumer health concerns via new, differentiated health products.
We apply consumer market insights and our extensive experience in pharmaceutical delivery science to help our customers improve bioavailability, targeted delivery, swallowability, taste and odor masking of their nutritionals. Our technology enables unique combination products and provides visually appealing dosage forms that meet the expectations of today’s health-conscious consumers.
We also bring exceptional service capabilities, global regulatory expertise, and expert technical service to support our customers in quickly delivering differentiated nutritional products to market.
Myriade
Website: http://www.myriadelab.com/en/
Myriade is a French company created in 2017 that develops an innovative nanoscale imaging technology: the VIDEODROP
Based on the principles of interferometry, the Videodrop makes it possible to visualize living nanoparticles in the range of 30 nm and 10 microns without labeling, in real time and in a single drop.
The Videodrop processing algorithms compute the concentration and size distribution of the nanoparticles and enable to analyze complex mixtures of phages (T4, lambda) for applications in phagotherapy, continuously monitor viral vector solutions (Lentiviruses, adenoviruses) for gene and cell therapy, and distinguish the different types of EVs to vectorize, diagnose or treat
Berkley Lights
Website: https://www.berkeleylights.com/
OUR MISSION
We find the best cells.
Discovery of cellular therapies, biopharmaceuticals, and other cell-based products depends on precise, time-consuming, cell-by-cell manipulations. But biologists need to move faster and more efficiently to meet today’s scientific demands. Our mission is to accelerate the use of cell-based products by providing researchers access to the Berkeley Lights Platform to find the best cells in a fraction of the time and at a fraction of the cost of traditional methods.
PeproTech
Website: http://www.peprotech.com
Established in 1988 by a group of scientists, PeproTech is a privately owned biotechnology company focusing on the development and manufacture of high quality cytokine products for the life-science and cell therapy markets. Over the past 30 years the company has grown into a global enterprise with state-of-the-art manufacturing facilities in the US, and offices around the world.
With over 2,000 products PeproTech has developed and refined innovative protocols to ensure quality, reliability and consistency.
Our mission is to provide the highest quality products to support the needs of today’s scientists and researchers.
Please contact: 800-436-9910 or [email protected]
Sexton Biotechnologies
Website: http://www.sextonbio.com
Sexton Biotechnologies is a company focused on the development and sales of bioproduction tools for cell and gene therapy founded in 2019, located in Indianapolis, IN. Sexton develops purpose-built CGT tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points, and labor costs. Sexton's portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems and human platelet lysate growth supplements.
Media Partners
CheckRare
Website: https://checkrare.com/
CheckRare is a learning platform for health care professionals and patients. Our platform allows users to gain insight and learn about rare diseases, current and emerging therapies, clinical trials, and the BioPharma companies behind them. Our peer-to-peer content is a trusted source for education and industry-related content. Our native content and sponsored programs are developed through our website, e-newsletter, social media platforms, and live meetings. We are a trusted, strategic partner with all major organizations in the global network of rare disease advisors and advocates. There is no fee to register on CheckRare and all content is free of charge.
World Pharma Today
Website: https://www.worldpharmatoday.com/
Please visit our website for more information.Gene Therapy Net
Website: http://www.genetherapynet.com
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
TESTIMONIALS
Agenda Preview
We're still finalising more speakers for the OCTS USA 2021, but please do complete your details and take a look at our agenda preview for what's instore.
Download agenda preview
WHO WILL BE THERE
Network with industry experts from:
- Big pharma and biotech
- Cell Therapy Academics and clinicians
- Process standardisation - technology/services
- Logistics companies - cell storage/transport
- Service providers - CRO’s, Consultants, Government
Past attendees include:
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.